Last edition
News about Market
Cipla Partners with CTTQ to Develop and Commercialise HER2-Targeted ADC in Emerging Markets
Cipla and CTTQ partner to expand access to TQB2102, an investigational HER2 bispecific ADC being evaluated across HER2-expressing cancers.
Market | 01/09/2026 | By News Bureau
Eli Lilly to Acquire Merida Biosciences in Deal Valued at Up to USD 2.875 Billion
Eli Lilly will acquire Merida Biosciences for up to $2.875 billion to advance precision therapies targeting disease-causing autoantibodies.
Market | 01/09/2026 | By News Bureau
RedHill Biopharma Divests Talicia Business to Apotex for USD 18 Million Upfront
RedHill Biopharma has divested its 70 percent interest in Talicia to Apotex in a deal valued at up to USD 53 million, including potential sales milestones.
Market | 01/09/2026 | By News Bureau
BeOne Medicines reports positive Phase 3 results showing improved overall survival with Ziihera-based regimens in patients with HER2-positive gastroesophageal adenocarcinoma.
Market | 01/09/2026 | By News Bureau
Teva Plans Acquisition of Novel Neuroscience Product
Teva plans to acquire BXCL501, a novel dexmedetomidine sublingual film under the US Food and Drug Administration (FDA) review for potential at-home treatment of acute agitation in adults with schizophrenia or bipolar disorder.
Market | 01/09/2026 | By News Bureau
Aurobindo Pharma's Lannett Launches Generic Advair Diskus in US
Aurobindo Pharma’s Lannett launches generic Advair Diskus in the US in 100/50 mcg and 250/50 mcg strengths for asthma and COPD treatment.
Market | 31/08/2026 | By News Bureau
Bayer Files Japan Application to Expand Finerenone Use in Non-Diabetic CKD
Bayer’s Japan filing, backed by Phase III FIND-CKD data showing slower kidney function decline and a 23 percent reduction in cardiovascular-kidney events, seeks to expand finerenone’s potential role in treating adults with non-diabetic CKD and addressing a significant unmet medical need.
Market | 31/08/2026 | By News Bureau
Entod Pharmaceuticals Launches Project AXIOM to Explore Novel Myopia Therapy
Entod Pharmaceuticals has launched Project AXIOM, an India-led research programme exploring retinal dopaminergic modulation as a potential approach to slowing progressive myopia.
Market | 27/08/2026 | By News Bureau
Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
Agilent Technologies reports strong third-quarter fiscal 2026 results and raises its FY26 revenue growth, margin expansion and non-GAAP EPS guidance.
Market | 27/08/2026 | By News Bureau
ASPA and CRISIL Report Finds 89 Percent of Consumers Have Purchased Counterfeit Products in India
ASPA’s latest report highlights the widespread presence of counterfeit products across key sectors, urging brands, regulators and consumers to strengthen authentication and traceability efforts.
Market | 26/08/2026 | By News Bureau | 119
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy